ARTLVSBRTX• 3 Months (Normalized)
ARTL vs BRTX (Artelo Biosciences Inc. vs BioRestorative Therapies Inc. Common Stock (NV))
Showing Closing Date Range from Jul 2 to Sep 30, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ARTL Performance $4.54
+%
Artelo Biosciences Inc.
Normalized Baseline0.00%
BRTX Performance $2.31
+477.5%
BioRestorative Therapies Inc. Common Stock (NV)
Normalized Baseline0.00%
Alpha Spread Margin BRTX LEADS
-477.5 pts
BRTX outperforming by 477.50 percentage points
ARTLBRTX
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ARTL BRTX
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(61 dates)
| Date | ARTL Price | ARTL Gain (%) | BRTX Price | BRTX Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 28, 2026 | $- | $2.31 | +477.50% | - | |
| Sep 25, 2026 | $4.54 | -54.55% | $2.55 | +537.50% | -592.05% |
| Sep 24, 2026 | $5.17 | -48.25% | $2.51 | +527.50% | -575.75% |
| Sep 23, 2026 | $7.31 | -26.83% | $2.60 | +550.00% | -576.83% |
| Sep 22, 2026 | $4.15 | -58.46% | $2.55 | +537.50% | -595.96% |
| Sep 21, 2026 | $4.10 | -58.96% | $2.71 | +577.50% | -636.46% |
| Sep 18, 2026 | $3.94 | -60.56% | $2.69 | +572.50% | -633.06% |
| Sep 17, 2026 | $3.97 | -60.26% | $2.66 | +563.75% | -624.01% |
| Sep 16, 2026 | $3.75 | -62.46% | $2.55 | +537.50% | -599.96% |
| Sep 15, 2026 | $5.34 | -46.55% | $2.64 | +560.00% | -606.55% |
| Sep 14, 2026 | $4.87 | -51.25% | $2.70 | +575.00% | -626.25% |
| Sep 11, 2026 | $5.43 | -45.65% | $2.67 | +567.50% | -613.15% |
| Sep 10, 2026 | $5.63 | -43.64% | $2.76 | +590.00% | -633.64% |
| Sep 09, 2026 | $5.98 | -40.14% | $2.74 | +585.00% | -625.14% |
| Sep 08, 2026 | $6.19 | -38.04% | $- | - |
Page 1 of 5